Inho Kim, MD
Board Certifications
American Board of Emergency Medicine
Affiliations
Emory
Education & Training
- Medical School: Medical College of Georgia
- Residency: New York Presbyterian Columbia
Fellowships
Oregon Health & Science University
Locations and Directions
Grady Memorial Hospital
Emergency Care: 24 hours a day, 365 days a year
Outpatient Care: Monday-Friday: 8 a.m. – 5 p.m.
Visiting hours are from 8 a.m. – 10:30 p.m. daily
Publications
- Multi-Cycle Dosimetry of the Albumin-Binding Prostate-Specific Membrane Antigen Ligand [Lu]Ludotadipep in Metastatic Androgen Pathway Modulator-Resistant Prostate Cancer with Adjusted Red Marrow Modeling.
Ha S, O JH, Park C, Boo SH, Shin D, Moon HW, Yoo IR, Kim IH, Lee JY
Pharmaceutics. 2026;
PMID: 42942858 - Pretreatment Serum GDF-15 and Features of Clinical Vulnerability in Advanced Pancreatic Ductal Adenocarcinoma.
Lee JH, Shin K, Hong TH, Kim IH, Hong SH, Lee M, Park SJ
Journal of clinical medicine. 2026;
PMID: 42941309 - Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S, Kim HJ, Cheong JW, Shin HJ, Kong JH, Sohn SK, Yoon SS, Zang DY, Jung CW, Kim JA, Lee SE, Lee WS, Choi Y, Kim I, Han JJ, Kim MK, Chong SY, Kim DJ, Jo DY, Kim H, Kwak JY, Lee JH, Uhm J, Lee S, Lee MY, Kim DW
Annals of hematology. 2026;
PMID: 42925414 - Denosumab Therapy Duration and Osteonecrosis of the Jaw and Skeletal Events in Bone-Metastatic Prostate Cancer.
Kim S, Jung S, Bu S, Kim JW, Pyo SW, Lee GJ, Chun SH, Kim IH, Park SS, Choi S
JAMA network open. 2026;9(10):e2639765.
PMID: 42905706 - Initial Enfortumab Vedotin Dose Reduction and Outcomes in Pretreated Advanced Urothelial Carcinoma.
Kim IH, Kim CG, Jo J, Jung EH, Park JH, Bae WK, Huh SJ, Choi YJ, Im HS, Lee HJ, Lee K, Lee MY, Park JH, Kim HJ, Song HN, Kim H, Shin SH, Park I
JAMA network open. 2026;9(10):e2639846.
PMID: 42905705 - Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study.
Wang F, Lin CY, Sun JM, Lu CH, Zhu X, Chen Z, Zhao Q, Kim IH, Pan Y, Zhang J, Chen Z, Tougeron D, Kim SB, Van Cutsem E, Zaanan A, Rivera F, Dechaphunkul A, Zuo Y, Wan Q, Zhang J, Zhou J, Xu RH
Nature communications. 2026;
PMID: 42901884 - Electrolyte Bonding Engineering for Highly Uniform GeTe-Based CBRAM and Parallel Hebbian Learning in Selector-Free Hopfield-Type Associative Networks.
Bang J, Hwang J, Kang U, Oh S, Lee K, Park J, Lee Y, Jang HJ, Park S, Jeong Y, Kim I, Park JK, Lee S
ACS applied materials & interfaces. 2026;18(38):52555-52563.
PMID: 42765726 - Age- and sex-adjusted genomic differences between Korean and Beat AML cohorts.
Kim M, Song IC, Park J, Lee C, Kim MY, Sohn SK, Yhim HY, Park Y, Kim I, Shin HJ, Park SK, Kim SH, Cheong JW, Lee HS, Lee H, Bae SH, Choi Y, Lee HG, Do YR, Han JJ, Kim MK, Park S, Cho BS, Kim HJ, Kim HJ, Ahn JS
Blood advances. 2026;10(22):7520-7524.
PMID: 42710088 - Addition of low-dose antithymocyte globulin to post-transplant cyclophosphamide for effective graft-versus-host disease prophylaxis in peripheral blood stem cell transplantation.
Kim DH, Park SY, Cho H, Byun JM, Shin DY, Koh Y, Kim I, Hong J
Transplant immunology. 2026;
PMID: 42628584 - BeetleBot: An integrated bioinspired soft robot for multimodal sensing and adaptive interaction.
Kim I, Yao DR, Yin S, Tran-Ngoc PT, Min J, Ng N, Heng W, Li J, Sadri B, Sato H, Kim SO, Gao W
Science advances. 2026;12(34):eaeg8849.
PMID: 42616889
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.